相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture
James R. Turk et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
Jonas Bovijn et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
VSMC-specific EP4 deletion exacerbates angiotensin II-induced aortic dissection by increasing vascular inflammation and blood pressure
Hu Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Vascular smooth muscle cells in atherosclerosis
Gemma L. Basatemur et al.
NATURE REVIEWS CARDIOLOGY (2019)
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
Chao Liang et al.
NATURE COMMUNICATIONS (2019)
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
PSRC1 overexpression attenuates atherosclerosis progression in apoE-/- mice by modulating cholesterol transportation and inflammation
Kai Guo et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration
Zong-Kang Zhang et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis
Chao Liang et al.
NATURE COMMUNICATIONS (2018)
Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
Smriti Murali Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
Zhenjian Zhuo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Monocytes and macrophages in abdominal aortic aneurysm
Juliette Raffort et al.
NATURE REVIEWS CARDIOLOGY (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
Fangfei Li et al.
NATURE COMMUNICATIONS (2017)
Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL
Baocai Wang et al.
BIOLOGY OPEN (2017)
Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles
Sijin Guo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
Defang Li et al.
NATURE COMMUNICATIONS (2016)
Heme oxygenase-1 deficiency exacerbates angiotensin II-induced aortic aneurysm in mice
Yen-Chun Ho et al.
ONCOTARGET (2016)
Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats
Yan Gao et al.
SCIENTIFIC REPORTS (2016)
G-quadruplex aptamer targeting Protein A and its capability to detect Staphylococcus aureus demonstrated by ELONA
Regina Stoltenburg et al.
SCIENTIFIC REPORTS (2016)
Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers
Yuanyuan Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts
Jin Liu et al.
BIOMATERIALS (2015)
The Effects of Atorvastatin on the Prevention of Osteoporosis and Dyslipidemia in the High-Fat-Fed Ovariectomized Rats
Sien Lin et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy
Chao Liang et al.
NATURE MEDICINE (2015)
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice
Katherine Perschbacher et al.
NUCLEIC ACID THERAPEUTICS (2015)
Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
Dae Hyun Kim et al.
PLOS ONE (2015)
A Peptide Antagonist of Thrombospondin-1 Promotes Abdominal Aortic Aneurysm Progression in the Angiotensin II-Infused Apolipoprotein-E-Deficient Mouse
Smriti M. Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
miR-214 targets ATF4 to inhibit bone formation
Xiaogang Wang et al.
NATURE MEDICINE (2013)
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Verena Boschert et al.
PLOS ONE (2013)
ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion
Jolanta M. Siller-Matula et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
Ge Zhang et al.
NATURE MEDICINE (2012)
Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling
Ka To Shum et al.
BIOCHEMICAL JOURNAL (2011)
Patients With Sclerosteosis and Disease Carriers: Human Models of the Effect of Sclerostin on Bone Turnover
Antoon H. van Lierop et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice
Alan Daugherty et al.
CLINICAL SCIENCE (2010)
First Missense Mutation in the SOST Gene Causing Sclerosteosis by Loss of Sclerostin Function
Elke Piters et al.
HUMAN MUTATION (2010)
Development of DNA aptamers using Cell-SELEX
Kwame Sefah et al.
NATURE PROTOCOLS (2010)
Genetic Mosaic Dissection of Lis1 and Ndel1 in Neuronal Migration
Simon Hippenmeyer et al.
NEURON (2010)
Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION
Vaclav Veverka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The CMV early enhancer/chicken β actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors
Annika N. Alexopoulou et al.
BMC CELL BIOLOGY (2008)
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation
Rutger L. van Bezooijen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Aptamers evolved from live cells as effective molecular probes for cancer study
Dihua Shangguan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dual luciferase assay system for rapid assessment of gene expression in Saccharomyces cerevisiae
DS McNabb et al.
EUKARYOTIC CELL (2005)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pharmacokinetics and biodistribution of novel aptamer compositions
JM Healy et al.
PHARMACEUTICAL RESEARCH (2004)
An improved method for the in vitro evolution of aptamers and applications in protein detection and purification -: art. no. e110
MB Murphy et al.
NUCLEIC ACIDS RESEARCH (2003)
The natural history of sclerosteosis
H Hamersma et al.
CLINICAL GENETICS (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
A Daugherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
